Filing Details
- Accession Number:
- 0001140361-14-037654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-08 17:17:08
- Reporting Period:
- 2014-10-08
- Filing Date:
- 2014-10-08
- Accepted Time:
- 2014-10-08 16:17:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1557883 | Dermira Inc. | DERM | Pharmaceutical Preparations (2834) | 273267680 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1288452 | Bay City Capital Llc | 750 Battery Street Ste 400 San Francisco CA 94111 | Yes | No | Yes | No | |
1401826 | Bay City Capital Fund V, L.p. | 750 Battery Street Suite 400 San Francisco CA 94111 | No | No | Yes | No | |
1409813 | Bay City Capital Fund V Co-Investment Fund, L.p. | 750 Battery Street Suite 400 San Francisco CA 94111 | No | No | Yes | No | |
1461543 | Bay City Capital Management V Llc | 750 Battery Street, Suite 400 San Francisco CA 94111 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-10-08 | 3,356,337 | $0.00 | 3,373,255 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2014-10-08 | 67,820 | $16.00 | 3,441,075 | No | 4 | P | Indirect | See footnotes |
Common Stock | Acquisiton | 2014-10-08 | 63,958 | $0.00 | 64,280 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2014-10-08 | 1,292 | $16.00 | 65,572 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
No | 4 | C | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2014-10-08 | 2,337,590 | $0.00 | 2,337,590 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2014-10-08 | 44,545 | $0.00 | 44,545 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-10-08 | 643,066 | $0.00 | 643,066 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-10-08 | 12,254 | $0.00 | 12,254 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2014-10-08 | 375,681 | $0.00 | 375,681 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2014-10-08 | 7,159 | $0.00 | 7,159 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- In connection with the consummation of the Issuer's initial public offering on October 8, 2014, each share of Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. All shares of Common Stock issued upon conversion were aggregated.
- Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. Fred Craves, a Managing Director of BCC, is a member of the Issuer's Board of Directors.
- Represent securities held by Fund V, including indirect interests of BCC and Management V. BCC and Management V each disclaims beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- Represent securities held by Co-Investment V, including indirect interests of BCC and Management V. BCC and Management V each disclaims beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- None.